Yokosuka, Japan
Yokosuka, Japan

Time filter

Source Type

News Article | November 3, 2016
Site: globenewswire.com

HERSHEY, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Penn State Health has selected Cerner Millennium Revenue Cycle™, a patient-centric financial management platform designed to optimize provider and user workflow. The new platform will be integrated with the existing Cerner electronic health record (EHR) at the Milton S. Hershey Medical Center, resulting in a Clinically Driven Revenue Cycle™ across the health system, including more than 60 clinics. As part of the expanded relationship, Cerner will also extend the clinical and financial health information technology system to Penn State Health St. Joseph, previously St. Joseph Regional Health Network. “Having one integrated platform will support our efforts to create seamless coordination and collaboration among our departments and venues of care,” said Stephen Massini, chief financial officer, Penn State Health. “Incorporating clinical data into our revenue cycle processes will enable a better experience for our patients and providers and enhance our ability to holistically manage our patient’s financial responsibility.” Cerner’s Clinically Driven Revenue Cycle is designed to support clinicians and staff to update the billing process throughout the patient’s visit, enhance clinical documentation to help improve reimbursement and limit claims errors. Patients will benefit by having direct access to their clinical results and a streamlined financial experience, including visibility of their financial liability from a single source. “This expanded relationship makes Penn State Health a robust academic client with an integrated health IT system that supports the delivery of high quality care across the continuum,” said Dick Flanigan, president of Cerner HS. “We look forward to providing Penn State Health with a platform that works for the organization versus the organization working around a disrupted and disparate system.” About Penn State Health Penn State Health is a not-for-profit, tax-exempt corporation, established by Penn State for oversight of its health care enterprises and jointly owned health care organizations, to help meet the health needs of people and communities across Pennsylvania. Penn State Health includes several hospitals, including St. Joseph Medical Center in Reading, Pa., and the Milton S. Hershey Medical Center in Hershey, Pa., as well as their respective outpatient medical group practices. The system also includes Penn State Children’s Hospital and Penn State Cancer Institute, and jointly owned health care providers, including Hershey Outpatient Surgery Center, Hershey Endoscopy Center, Horizon Home Healthcare and the Pennsylvania Psychiatric Institute. Penn State Health shares an integrated strategic plan and operations with Penn State College of Medicine, the University’s medical school. About Cerner Cerner’s health information technologies connect people, information and systems at more than 25,000 provider facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs. Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. Nasdaq: CERN. For more information about Cerner, visit cerner.com, read our blog at blogs.cerner.com, connect with us on Twitter at twitter.com/cerner and on Facebook at facebook.com/cerner. Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.

Leung W.K.,University of Hong Kong | Leung W.K.,Endoscopy Center | Tang V.,University of Hong Kong | Tang V.,Endoscopy Center | Lui P.C.W.,Union Hospital
Journal of Digestive Diseases | Year: 2012

Objective: The aim was to determine the detection rates and characteristics of large or proximal serrated polyps in Chinese patients undergoing screening colonoscopy. Methods: Consecutive screening colonoscopies performed between 2008 and 2011 were analyzed. Serrated polyps consisted of all hyperplastic polyps, sessile serrated adenomas and traditional serrated adenomas. Large serrated polyps were defined as serrated polyps with a diameter≥10mm. Lesions proximal to the descending colon were considered as proximal lesions. Advanced neoplasia included invasive adenocarcinomas, adenomas with high grade dysplasia, adenomas with any villous histology and tubular adenomas≥10mm. Results: In total, 1282 colonoscopies were included. The detection rates for adenoma, advanced neoplasia, proximal serrated polyps and large serrated polyps were 26.1%, 10.5%, 7.2% and 2.3%, respectively. There was a significant association between synchronous advanced neoplasia and large serrated polyps (P=0.002) or proximal serrated polyps (P=0.013). Age ≥55 years (OR 1.9, 95% CI 1.2-2.8) and the presence of advanced neoplasia (OR 1.8, 95% CI 1.0-3.1) were significantly associated with the presence of large or proximal serrated polyps. Males had more advanced neoplasia (OR 2.0, 95% CI 1.4-2.9), but not more large or proximal serrated polyps, than females. Conclusions: Large and proximal serrated polyps were detected in 2.3% and 7.2% of Chinese patients undergoing screening colonoscopies, respectively. Individuals with large or proximal serrated polyps have a higher risk of synchronous advanced neoplasia. © 2012 The Authors. Journal of Digestive Diseases. © 2012 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Yu M.-A.,Interventional Ultrasound Center | Yao L.,Endoscopy Center | Zhang L.,China Japan Friendship Hospital | Peng L.,Interventional Ultrasound Center | And 4 more authors.
International Journal of Hyperthermia | Year: 2015

Background: Recurrent and persistent secondary hyperparathyroidism (SHPT) nodules have an incidence of 10–70% after surgery. The treatment of recurrent and persistent SHPT nodules is a challenge, and surgical resection of difficult-to-reach or post-operative adhesions often fails. Purpose: The aim of this research was to study the safety and effectiveness of microwave ablation (MWA) for recurrent and persistent SHPT. Materials and methods: This was a retrospective study of 11 patients enrolled with a total of 16 nodules, and MWA was employed to manage SHPT. The laboratory test results, including the intact parathyroid hormone (iPTH), serum calcium, phosphorus and alkaline phosphatase (ALP) levels, improvement of SHPT-related symptoms after ablation, and complications during and after MWA were recorded and analysed. Results: After ablation the value of iPTH was markedly decreased from 1570 ± 1765 pg/mL to 287 ± 239 pg/mL 1 day after MWA (p < 0.05). The levels of serum calcium and phosphorus decreased from 2.51 ± 0.23 mmol/L to 2.06 ± 0.27 mmol/L (p < 0.001) and 1.80 ± 0.43 mmol/L to 1.48 ± 0.32 mmol/L (p < 0.05), respectively, 1 day after MWA. There was no significant difference in the ALP value before and after MWA (p > 0.05). The clinical symptoms, including ostalgia, pruritus, disability, and restless legs, improved after MWA. Minor complications and side effects encountered during or after MWA include haematoma (1/11, 9%), transient hoarseness (2/11, 18.2%), hypocalcemia (6/11, 54.5%). No major complication occurred. Conclusion: MWA may be safe and effective to manage recurrent and persistent SHPT nodules; a definite conclusion needs to expand the sample size with a longer follow-up time. © 2015 Taylor & Francis.

Sugimoto S.,Yokohama Municipal Citizens Hospital | Sugimoto S.,Keio University | Hosoe N.,Keio University | Mizukami T.,Endoscopy Center | And 11 more authors.
Digestive Endoscopy | Year: 2014

Background and Aim Although intestinal obstruction as a result of sigmoid volvulus (SV) may be successfully resolved using endoscopic detorsion, surgical treatment remains the main therapeutic strategy. We evaluated the endoscopic detorsion procedure using unsedated water-immersion colonoscopy for the treatment of SV. Methods A retrospective chart review was conducted on the clinical background and prognosis of 21 SV patients who underwent 71 endoscopic detorsion procedures using unsedated, water-immersion colonoscopy. Results In all, 14 (67%) male and seven (33%) female patients, with a mean age of 73 years (range, 54-95 years) were enrolled; 86% were >70 years of age. Among these patients, 90% had a background of key predisposing factors. In the 21 patients, endoscopic detorsion was successfully done using unsedated water-immersion colonoscopy. SV recurred in 10 patients at a median of 180 days. Endoscopic detorsion for recurrent SV was successfully achieved in all cases, and none of the secondary cases became severe. Only male patients were observed to experience three or more recurrent episodes of SV. Conclusions SV occurred most commonly in elderly patients with a surgical risk. Our experience suggests that conservative endoscopic treatment using unsedated water-immersion colonoscopy is a safe, reasonable, conservative endoscopic approach for elderly patients in the absence of necrotic findings. We currently use this procedure in most of our cases. © 2014 The Authors. Digestive Endoscopy © 2014 Japan Gastroenterological Endoscopy Society.

Sugimoto S.,Keio University | Mizukami T.,Endoscopy Center
World Journal of Gastroenterology | Year: 2015

Colonoscopy techniques combining or replacing air insufflation with water infusion are becoming increasingly popular. They were originally designed to reduce colonic spasms, facilitate cecal intubation, and lower patient discomfort and the need for sedation. These maneuvers straighten the rectosigmoid colon and enable the colonoscope to be inserted deeply without causing looping of the colon. Water-immersion colonoscopy minimizes colonic distension and improves visibility by introducing a small amount of water. In addition, since pain during colonoscopy indicates risk of bowel perforation and sedation masks this important warning, this method has the potential to be the favored insertion technique because it promotes patient safety without sedation. Recently, this water-immersion method has not only been used for colonoscope insertion, but has also been applied to therapy for sigmoid volvulus, removal of lesions, lower gastrointestinal bleeding, and therapeutic diagnosis of abnormal bowel morphology and irritable bowel syndrome. Although a larger sample size and prospective head-to-head-designed studies will be needed, this review focuses on the usefulness of water-immersion colonoscopy for diagnostic and therapeutic applications. © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.

Mizukami T.,Endoscopy Center | Ogata H.,Keio University | Hibi T.,Keio University
World Journal of Gastroenterology | Year: 2012

Colonoscopy sometimes causes pain during insertion, especially in difficult cases. Over-insufflation of air causes elongation or acute angulations of the colon, making passage of the scope difficult and causing pain. We previously reported a sedative-risk-free colonoscopy insertion technique, namely, "Water Navigation Colonoscopy". Complete air suction after water infusion not only improves the vision, but also makes water flow down to the descending colon, while the sigmoid colon collapses and shortens. While non-sedative colonoscopy can be carried out without pain in most cases, some patients do complain of pain. Most of these patients have abnormal colon morphology, and the pain is caused while negotiating the "hairpin" bends of the colon. The "hairpin" bends of the colon should be negotiated by gently pushing the full-angled colonoscope. The proximal 10-20 cm from the angulated part of the conventional colonoscope is stiff, with a wide turning radius, therefore, a conventional colonoscope cannot be negotiated through the "hairpin" bends of the colon without stretching them and causing pain. The "passive-bending colonoscope" has a flexible tip with a narrow turning radius, so that the scope can be negotiated through the "hairpin" bends of the colon with a minimum turning radius and minimal discomfort. Therefore, the intubation and pain-reducing performance of the "passive-bending colonoscope" was assessed in difficult cases. © 2012 Baishideng.

Jo H.-G.,Wonkwang University | Amarbat B.,Endoscopy Center | Jeong J.-W.,Wonkwang University | Song H.-Y.,Wonkwang University | And 2 more authors.
Clinical Endoscopy | Year: 2015

Drainage of pancreatic abscesses is required for effective control of sepsis. Endoscopic ultrasound (EUS)-guided endoscopic drainage is less invasive than surgery and prevents local complications related to percutaneous drainage. Endoscopic drainage with stent placement in the uncinate process of the pancreas is a technically difficult procedure. We report a case of pancreatic abscess treated by repeated EUS-guided aspiration and intravenous antibiotics without an indwelling drainage catheter or surgical intervention. © 2015 Korean Society of Gastrointestinal Endoscopy.

PubMed | Wonkwang University and Endoscopy Center
Type: Journal Article | Journal: Clinical endoscopy | Year: 2015

Drainage of pancreatic abscesses is required for effective control of sepsis. Endoscopic ultrasound (EUS)-guided endoscopic drainage is less invasive than surgery and prevents local complications related to percutaneous drainage. Endoscopic drainage with stent placement in the uncinate process of the pancreas is a technically difficult procedure. We report a case of pancreatic abscess treated by repeated EUS-guided aspiration and intravenous antibiotics without an indwelling drainage catheter or surgical intervention.

Dai Z.,Endoscopy Center | Zhou D.,Endoscopy Center | Hu J.,Endoscopy Center | Zhang L.,Tianjin Medical University | And 6 more authors.
Oncology Letters | Year: 2013

The aim of the present study was to compare the clinical effectiveness of an iodine-eluting stent with a conventional stent in patients with advanced esophageal cancer. Patients with malignant esophageal cancer were randomly assigned to receive a conventional stent (group A) or an iodine-eluting stent (group B). Following implantation, the relief from dysphagia, survival time, routine blood tests, thyroid function examination and complications were compared in the two groups. Groups A and B consisted of 36 and 31 patients, respectively. The mean value that the dysphagia score decreased by was significantly lower in group A (0.83) compared with group B (1.65). The median survival time was longer in group B compared with group A (P=0.0022). No significant differences were observed in the severe complications between the two groups (P=0.084). The iodine-eluting esophageal stent is a relatively safe, feasible and effective treatment for malignant esophageal strictures.

Loading Endoscopy Center collaborators
Loading Endoscopy Center collaborators